Seung Soo Lee1, Ho Young Chung2, Oh Kyoung Kwon3, Wansik Yu3. 1. Department of Surgery, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 700-721, Republic of Korea. 2. Department of Surgery, Kyungpook National University Hospital, 130 Dongdeok-ro, Jung-gu, Daegu 700-721, Republic of Korea. Electronic address: hychung@knu.ac.kr. 3. Gastric Cancer Center, Kyungpook National University Medical Center, 807 Hoguk-ro, Buk-gu, Daegu 702-210, Republic of Korea.
Abstract
INTRODUCTION: This study investigated how total gastrectomy (TG), along with memories of cancer, affect the subjective wellness of survivors long after surgery. Rational approaches for effectively improving the quality of life (QoL) of these survivors were suggested. METHODS: Between 2008 and 2013, QoL data of gastric cancer patients who underwent a curative TG, were obtained at 5-year postoperative follow-up visits (5-year survivors) and at visits beyond 5 years (long-term survivors). The control groups for these survivor groups were constructed from volunteers who visited our health-examination center for annual medical checkups. The Korean versions of the European Organization for Research and Treatment (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30) and the gastric cancer specific module, the EORTC QLQ-STO22, were used to assess QoL. RESULTS: Five-year survivors showed worse QoL compared to the control group in role functioning, social functioning, nausea/vomiting, appetite loss, financial difficulties, reflux, eating restrictions, taste, and body image, and better QoL in the emotional and cognitive functioning scales. In long-term survivors, deterioration in QoL were still apparent in financial difficulties, reflux, and eating restrictions, while QoL differences in the remaining scales had diminished. DISCUSSION: Surviving 5 years after TG does not result in living in a carefree state in terms of QoL. After 5 postoperative years, survivors still need extended care for deteriorated QoL indicators due to symptomatic, behavioral, and financial consequences of surgery. CONCLUSION: While relevant clinical and institutional approaches are required for corresponding declines in QoL, such efforts must extend beyond 5 postoperative years.
INTRODUCTION: This study investigated how total gastrectomy (TG), along with memories of cancer, affect the subjective wellness of survivors long after surgery. Rational approaches for effectively improving the quality of life (QoL) of these survivors were suggested. METHODS: Between 2008 and 2013, QoL data of gastric cancerpatients who underwent a curative TG, were obtained at 5-year postoperative follow-up visits (5-year survivors) and at visits beyond 5 years (long-term survivors). The control groups for these survivor groups were constructed from volunteers who visited our health-examination center for annual medical checkups. The Korean versions of the European Organization for Research and Treatment (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30) and the gastric cancer specific module, the EORTC QLQ-STO22, were used to assess QoL. RESULTS: Five-year survivors showed worse QoL compared to the control group in role functioning, social functioning, nausea/vomiting, appetite loss, financial difficulties, reflux, eating restrictions, taste, and body image, and better QoL in the emotional and cognitive functioning scales. In long-term survivors, deterioration in QoL were still apparent in financial difficulties, reflux, and eating restrictions, while QoL differences in the remaining scales had diminished. DISCUSSION: Surviving 5 years after TG does not result in living in a carefree state in terms of QoL. After 5 postoperative years, survivors still need extended care for deteriorated QoL indicators due to symptomatic, behavioral, and financial consequences of surgery. CONCLUSION: While relevant clinical and institutional approaches are required for corresponding declines in QoL, such efforts must extend beyond 5 postoperative years.
Authors: R Bausys; A Bausys; J Stanaitis; I Vysniauskaite; K Maneikis; B Bausys; E Stratilatovas; K Strupas Journal: Surg Endosc Date: 2018-12-03 Impact factor: 4.584
Authors: Nina Hallowell; Julia Lawton; Shirlene Badger; Sue Richardson; Richard H Hardwick; Carlos Caldas; Rebecca C Fitzgerald Journal: J Genet Couns Date: 2016-11-11 Impact factor: 2.537
Authors: Jennifer Straatman; Nicole van der Wielen; Pieter J Joosten; Caroline B Terwee; Miguel A Cuesta; Elise P Jansma; Donald L van der Peet Journal: Surg Endosc Date: 2015-08-27 Impact factor: 4.584
Authors: Yumi Lee; Myong Cheol Lim; Se Ik Kim; Jungnam Joo; Dong Ock Lee; Sang-Yoon Park Journal: Cancer Res Treat Date: 2016-02-12 Impact factor: 4.679
Authors: Gloria Fernández-Esparrach; José-Carlos Marín-Gabriel; Alberto H de Tejada; Eduardo Albéniz; Oscar Nogales; Andres J Del Pozo-García; Pedro J Rosón; Unai Goicotxea; Hugo Uchima; Alvaro Terán; Alvarez Alberto; Rodríguez-Sánchez Joaquín; Rivero-Sánchez Liseth; Santiago José Journal: United European Gastroenterol J Date: 2021-06-02 Impact factor: 4.623
Authors: Yae Su Jang; Bong Eun Lee; Gwang Ha Kim; Do Youn Park; Hye Kyung Jeon; Dong Hoon Baek; Dong Uk Kim; Geun Am Song Journal: Medicine (Baltimore) Date: 2015-08 Impact factor: 1.889